Arcus Biosciences annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Arcus Biosciences Revenue Growth & History (RCUS)
Arcus Biosciences reported $33.0M in revenue for fiscal 2025, a decrease of 35.29% from the previous fiscal year.
View full Arcus Biosciences company overviewArcus Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $33.0M | −$18.0M | −35.29% |
| 2024 | 2024-12-31 | $51.0M | $14.0M | +37.84% |
| 2023 | 2023-12-31 | $37.0M | −$1.0M | −2.63% |
| 2022 | 2022-12-31 | $38.0M | −$345.0M | −90.08% |
| 2021 | 2021-12-31 | $383.0M | $305.0M | +391.03% |
| 2020 | 2020-12-31 | $78.0M | $63.0M | +420.00% |
| 2019 | 2019-12-31 | $15.0M | $6.6M | +79.58% |
| 2018 | 2018-12-31 | $8.4M | $6.9M | +491.15% |
| 2017 | 2017-12-31 | $1.4M | — | — |
Arcus Biosciences quarterly revenue
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $33.0M | $25.0M | +312.50% |
| Q1 2026 | 2026-03-31 | $7.0M | −$1.0M | −12.50% |
| Q4 2025 | 2025-12-31 | $11.0M | −$12.0M | −52.17% |
| Q3 2025 | 2025-09-30 | $6.0M | −$1.0M | −14.29% |
| Q2 2025 | 2025-06-30 | $8.0M | −$3.0M | −27.27% |
| Q1 2025 | 2025-03-31 | $8.0M | −$2.0M | −20.00% |
| Q4 2024 | 2024-12-31 | $23.0M | $72.0M | +146.94% |
| Q3 2024 | 2024-09-30 | $7.0M | −$25.0M | −78.13% |
| Q2 2024 | 2024-06-30 | $11.0M | −$18.0M | −62.07% |
| Q1 2024 | 2024-03-31 | $10.0M | −$15.0M | −60.00% |
| Q4 2023 | 2023-12-31 | −$49.0M | −$9.0M | −22.50% |
| Q3 2023 | 2023-09-30 | $32.0M | −$1.0M | −3.03% |
| Q2 2023 | 2023-06-30 | $29.0M | $2.0M | +7.41% |
| Q1 2023 | 2023-03-31 | $25.0M | $7.0M | +38.89% |
| Q4 2022 | 2022-12-31 | −$40.0M | −$394.6M | −111.28% |
| Q3 2022 | 2022-09-30 | $33.0M | $23.5M | +248.80% |
| Q2 2022 | 2022-06-30 | $27.0M | $17.5M | +185.38% |
| Q1 2022 | 2022-03-31 | $18.0M | $8.5M | +90.25% |
| Q4 2021 | 2021-12-31 | $354.6M | $345.1M | +3637.93% |
| Q3 2021 | 2021-09-30 | $9.5M | −$55.1M | −85.34% |
| Q2 2021 | 2021-06-30 | $9.5M | $7.7M | +440.63% |
| Q1 2021 | 2021-03-31 | $9.5M | $7.7M | +440.63% |
| Q4 2020 | 2020-12-31 | $9.5M | −$263,000 | −2.70% |
| Q3 2020 | 2020-09-30 | $64.5M | $62.8M | +3587.43% |
| Q2 2020 | 2020-06-30 | $1.8M | $0 | 0.00% |
| Q1 2020 | 2020-03-31 | $1.8M | $0 | 0.00% |
| Q4 2019 | 2019-12-31 | $9.8M | $8.2M | +524.20% |
| Q3 2019 | 2019-09-30 | $1.8M | −$2.5M | −59.22% |
| Q2 2019 | 2019-06-30 | $1.8M | $500,000 | +40.00% |
| Q1 2019 | 2019-03-31 | $1.8M | $500,000 | +40.00% |
| Q4 2018 | 2018-12-31 | $1.6M | $312,000 | +24.96% |
| Q3 2018 | 2018-09-30 | $4.3M | $4.1M | +2532.52% |
| Q2 2018 | 2018-06-30 | $1.3M | — | — |
| Q1 2018 | 2018-03-31 | $1.3M | — | — |
| Q4 2017 | 2017-12-31 | $1.3M | — | — |
| Q3 2017 | 2017-09-30 | $163,000 | — | — |
Arcus Biosciences revenue growth trends
Over the last five reported fiscal years, revenue declined from $78.0M to $33.0M, a compound annual decline of 15.81%. Arcus Biosciences's latest reported quarter, Q2 2026, generated $33.0M in revenue, an increase of 312.50% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Arcus Biosciences source filings ↗